Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Cagatay, M. Aydin, Z. Gulbaran, R. Yildiz, L. Pur, A. Gul, M. Inanc, S. Kamali, B. Artim, Y. Cagatay, Z. Kilicarslan (Istanbul, Turkey). Observation results of 484 patients that use TNF alfa inhibitor in respect of the risk of tuberculosis. Eur Respir J 2008; 32: Suppl. 52, 3051

Member's Comments

No comment yet.

Related content which might interest you: The incidence of tuberculosis in patients taking anti TNF alpha therapy Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 Follow up results of patients receiving anti tumor necrosis antagonists and evaluation of risk of tuberculosis Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Follow up results for tuberculosis in patients who receive TNF antagonist treatment Source: Eur Respir J 2007; 30: Suppl. 51, 659s Year: 2007 Characteristics of new tuberculosis cases diagnosed during treatment with TNF-alpha antagonists Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Effectiveness of official recommendations on tuberculosis screening in patients on TNF antagonists Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 Diagnostic performance of the interferon gamma release assay in elderly patients and clinical factors to support the diagnosis of active tuberculosis Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 Our approach about latent tuberculosis infection in patients who are given anti-TNF alpha therapy Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Screening and monitoring of tuberculosis in patients on tumor necrosis factor antagonist therapy Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 Risk of tuberculosis in pediatric patients treated with biological agents Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children Year: 2020 The use of tumor necrosis factor alpha inhibitor pentoxifylline in the treatment of patients with I and II stages of pulmonary sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 542s Year: 2006 An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy Source: Eur Respir J 2014; 44: 1369-1372 Year: 2014 Comparison of LTBI screening strategies before TNF inhibitor treatment in inflammatory arthritis Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 Treatment and outcome of CRF patients with tuberculosis Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 Risk Factors for tuberculosis in patients on anti-TNF treatment Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Screening and monitoring of tuberculosis in patients on biologics treatment Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012 Long-term results of treatment with bedaquiline in patients with drug-resistant tuberculosis Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Factors affecting the efficacy of treatment of MDR/XDR TB patients receiving bedaquiline Source: International Congress 2019 – Tuberculosis: a public health approach Year: 2019 Comparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapy Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Antiviral biomarkers are upregulated in sputum cells following administration of inhaled interferon beta to COPD patients Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 Relationship of interleukin 10 1082 G/A gene polymorphism with the duration of nephrotoxic onset due to anti tuberculosis drugs in multi drug resistant tuberculosis patients Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019